kotak-logo

27 March 2026 Stock Update: Oil Hits $100, Markets Turn Weak – HFCL, Reliance in Spotlight

stocks-to-watch

Set Kotak Neo as your preferred content on Google.

Add as preferred source on Google

Indian markets start cautiously on 27 March 2026 as oil hits $100. Infosys deals, LIC tax demand, HFCL, and Reliance news keep investors on alert.

Indian markets look set for a cautious start on Friday, 27 March 2026. The weakness lines up with what’s happening globally. Asian markets are already trading lower, and investors are still trying to make sense of developments in West Asia. At the same time, crude oil moving past $100 per barrel is back on traders’ radar.

Infosys: The company is picking up Optimum Healthcare IT for $465 million and Stratus Global for $95 million. The idea is simple: build scale in healthcare and insurance tech in the US.

Life Insurance Corporation (LIC): The insurer has received a tax demand of ₹7,100 crore, including interest, which could weigh on the stock.

HDFC Bank: Sunita Maheshwari has been re-appointed as an Independent Director. No surprise move here, but it keeps board stability intact.

Yes Bank: Vinay Muralidhar Tonse has taken over as CEO and MD. Leadership changes in banks usually get noticed quickly by the market.

HFCL: The company is planning to raise ₹555 crore and has cleared a ₹580 crore investment for a new manufacturing facility. This points to a push for capacity expansion and operational integration.

Power Mech Projects: A large order worth ₹1,563 crore is no longer in the book after a tender was cancelled. That leaves a visible gap in near-term orders.

Reliance Industries: The company has responded to reports around Iranian crude oil purchase, calling them incorrect. The clarification comes at a time when oil-related news is being closely tracked.

Azad Engineering: An eight-year supply agreement with Mitsubishi Heavy Industries puts the company on a longer-term export track.

Brigade Enterprises: A new housing project in Bengaluru has a revenue potential of ₹700 crore, adding to the existing projects in the pipeline.

Aurobindo Pharma: Its subsidiary has entered into a tie-up with STADA to distribute biosimilars in Europe.

Across Asia, the tone is clearly negative. Japan’s Nikkei is down about 0.94%, Hong Kong’s Hang Seng has slipped 0.09%, and China’s CSI 300 is lower by around 0.25%. South Korea’s Kospi has seen a sharper fall of nearly 2.94%, making it one of the weakest in the region today.

The pressure ties back to global developments. The US has pushed back its deadline related to Iran’s energy infrastructure by 10 days to 6 April, keeping uncertainty alive rather than resolving it. Reports also suggest the extension came in exchange for oil shipments moving through the Strait of Hormuz, which has kept oil markets volatile.

Crude oil prices are reacting to the current environment. Brent crude has moved above $100 a barrel, a price point that usually makes import-dependent economies like India nervous. For companies, it means cost pressures, and for the market, it brings back the threat of inflation.

Also Read - Pre-Market 27 March 2026: What To Expect After Nifty’s 394-Point Rally

There is enough happening at the company level to keep things active. Deals, fundraises, and management changes are all in play. Infosys is expanding overseas, HFCL is investing in capacity, and banks are seeing leadership updates.

Even so, the broader direction may not be in their control. If global cues stay weak, they could overshadow everything else. So, the real question is will stock-specific action hold up, or will global factors end up steering the market today?

Sources

NDTV Profit

Business Standard

Moneycontrol

About the Author
Kotak News Desk
Kotak News Desk

Kotak News Desk brings you latest updates, expert insights, and market-ready ideas - helping you stay informed and invest smarter.

Connect on: Linkedin

...Read More
Did you enjoy this article?

0 people liked this article.